w 7 has been researched along with bay-k-8644 in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (27.27) | 18.7374 |
1990's | 7 (63.64) | 18.2507 |
2000's | 1 (9.09) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Glembotski, CC; McDonough, PM | 1 |
Sharp, GW; Yaney, GC | 1 |
Brown, JH; Glembotski, CC; Irons, CE; McDonough, PM; Sei, CA; Sprenkle, AB | 1 |
Ogawa, N; Ono, H; Yokota, S | 1 |
Bräutigam, M; Herken, H; Kittner, B | 1 |
Palmberg, L; Thyberg, J | 1 |
Cristòfol, RM; Rodríguez-Farré, E | 1 |
Barron, S; Serratosa, J; Tusell, JM | 1 |
Malik, KU; Nebigil, C | 1 |
Anderson, ME; Mazur, A; Roden, DM | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
11 other study(ies) available for w 7 and bay-k-8644
Article | Year |
---|---|
Induction of atrial natriuretic factor and myosin light chain-2 gene expression in cultured ventricular myocytes by electrical stimulation of contraction.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Atrial Natriuretic Factor; Cells, Cultured; Electric Stimulation; Fluorescent Antibody Technique; Gene Expression Regulation; Heart Ventricles; Myocardial Contraction; Myocardium; Myosins; Nifedipine; Rats; RNA, Messenger; Sulfonamides; Transcriptional Activation; Ventricular Function | 1992 |
Calmodulin and insulin secretion: use of naphthalenesulfonamide compounds.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calmodulin; Cell Line; Fura-2; In Vitro Techniques; Insulin; Insulin Secretion; Insulinoma; Islets of Langerhans; Kinetics; Male; Pancreatic Neoplasms; Rats; Rats, Inbred Strains; Sulfonamides | 1990 |
The alpha-adrenergic stimulation of atrial natriuretic factor expression in cardiac myocytes requires calcium influx, protein kinase C, and calmodulin-regulated pathways.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Agonists; Animals; Atrial Natriuretic Factor; Calcium; Calmodulin; Cells, Cultured; Gene Expression; Heart; Hydrolysis; Isoquinolines; Myocardium; Nifedipine; Phenylephrine; Phosphatidylinositols; Piperazines; Protein Kinase C; Rats; Sulfonamides | 1991 |
Inhibitory effects of trifluoperazine and chlorpromazine, calmodulin inhibitor, on autoregulation of renal blood flow.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Blood Pressure; Calcium Chloride; Calmodulin; Chlorpromazine; Dogs; Female; Homeostasis; Male; Renal Circulation; Sulfonamides; Trifluoperazine; Vasodilator Agents | 1987 |
PC12 cells: a model system for studying drug effects on dopamine synthesis and release.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Brocresine; Cells, Cultured; Cresols; Dihydroxyphenylalanine; Dopamine; Models, Biological; Nitrendipine; Pheochromocytoma; Potassium Chloride; Rats; Reserpine; Sulfonamides | 1987 |
The calcium antagonist nisoldipine and the calmodulin antagonist W-7 synergistically inhibit initiation of DNA synthesis in cultured arterial smooth muscle cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta; Calcium Channel Blockers; Calmodulin; Cells, Cultured; DNA Replication; Drug Synergism; Male; Microscopy, Electron; Muscle, Smooth; Muscle, Smooth, Vascular; Nifedipine; Nisoldipine; Platelet-Derived Growth Factor; Rats; Rats, Inbred Strains; Sulfonamides | 1987 |
Hippocampal noradrenaline release is modulated by gamma- and delta-hexachlorocyclohexane isomers: which mechanisms are involved?
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Animals; Calcium Channel Blockers; Calcium Channels; Chlorides; Hexachlorocyclohexane; Hippocampus; In Vitro Techniques; Isomerism; Norepinephrine; omega-Conotoxin GVIA; Peptides; Potassium; Rats; Sodium Channel Blockers; Sodium Channels; Sulfonamides; Tetrodotoxin | 1994 |
Anticonvulsant activity of calmodulin antagonist W-7 in convulsions induced by lindane and BayK-8644: effects in c-fos expression.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Anticonvulsants; Calcium Channels; Gene Expression; Genes, fos; Hexachlorocyclohexane; In Situ Hybridization; Male; Mice; RNA, Messenger; Seizures; Sulfonamides | 1994 |
Alpha adrenergic receptor subtypes involved in prostaglandin synthesis are coupled to Ca++ channels through a pertussis toxin-sensitive guanine nucleotide-binding protein.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channels; Cells, Cultured; GTP-Binding Proteins; In Vitro Techniques; Muscle, Smooth, Vascular; Naphthalenes; Pertussis Toxin; Phospholipases A; Phospholipases A2; Polycyclic Compounds; Prostaglandins; Rabbits; Receptors, Adrenergic, alpha; Sulfonamides; Tetradecanoylphorbol Acetate; Virulence Factors, Bordetella | 1993 |
Systemic administration of calmodulin antagonist W-7 or protein kinase A inhibitor H-8 prevents torsade de pointes in rabbits.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Agonists; Animals; Anti-Arrhythmia Agents; Blood Pressure; Calcium Channel Agonists; Calcium-Calmodulin-Dependent Protein Kinases; Calmodulin; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Electrocardiography; Enzyme Inhibitors; Heart Rate; Isoquinolines; Long QT Syndrome; Male; Methoxamine; Quaternary Ammonium Compounds; Rabbits; Sulfonamides; Torsades de Pointes | 1999 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |